The 39,59-cAMP-adenosine pathway (39,59-cAMP→59-AMP→ adenosine) and the 29,39-cAMP-adenosine pathway (29,39-cAMP→29-AMP/39-AMP→adenosine) are active in the brain. Oligodendrocytes participate in the brain 29,39-cAMP-adenosine pathway via their robust expression of 29,39-cyclic nucleotide 39-phosphodiesterase (CNPase; converts 29,39-cAMP to 29-AMP). Because Schwann cells also express CNPase, it is conceivable that the 29,39-cAMP-adenosine pathway exists in the peripheral nervous system. To test this and to compare the 29,39-cAMP-adenosine pathway to the 39,59-cAMP-adenosine pathway in Schwann cells, we examined the metabolism of 29,39-cAMP, 29-AMP, 39-AMP, 39,59-cAMP, and 59-AMP in primary rat Schwann cells in culture. Addition of 29,39-cAMP (3, 10, and 30 mM) to Schwann cells increased levels of 29-AMP in the medium from 0.006 6 0.002 to 21 6 2, 70 6 3, and 187 6 10 nM/mg protein, respectively; in contrast, Schwann cells had little ability to convert 29,39-cAMP to 39-AMP or 39,59-cAMP to either 39-AMP or 59-AMP. Although Schwann cells slightly converted 29,39-cAMP and 29-AMP to adenosine, they did so at very modest rates (e.g., 5-and 3-fold, respectively, more slowly compared with our previously reported studies in oligodendrocytes). Using transected myelinated rat sciatic nerves in culture medium, we observed a time-related increase in endogenous intracellular 29,39-cAMP and extracellular 29-AMP. These findings indicate that Schwann cells do not have a robust 39,59-cAMP-adenosine pathway but do have a 29,39-cAMP-adenosine pathway; however, because the pathway mostly involves 29-AMP formation rather than 39-AMP, and because the conversion of 29-AMP to adenosine is slow, metabolism of 29,39-cAMP mostly results in the accumulation of 29-AMP. Accumulation of 29-AMP in peripheral nerves postinjury could have pathophysiological consequences.